life md glp-1 EllieMD LifeMD TV Spot, 'GLP-1 Weight

Conclusion Semaglutide is increasingly used of for the treatment of type 2 diabetes

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Read the full article here: | 31 comments on LinkedIn

Here's what FDA approvals, ADA guidelines and recent trials actually say.

Learn How a Late Period Can Be a Sign of Many Health Factors, Not Just Pregnancy

Learn screening rules, timing, side effects, and what to ask your clinic before you apply.